Camber Capital Management LP Reata Pharmaceuticals Inc Transaction History

Camber Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$19.41 - $36.49 $19.4 Million - $36.5 Million	-1,000,000 Reduced 66.67%	500,000 $12.6 Million
Q1 2022 May 16, 2022	BUY	$24.12 - $39.6 $36.2 Million - $59.4 Million	1,500,000 New	1,500,000 $49.1 Million
Q4 2021 Feb 14, 2022	SELL	$25.61 - $110.96 $17.5 Million - $76 Million	-685,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$100.0 - $143.02 $22 Million - $31.5 Million	220,000 Added 47.31%	685,000 $68.9 Million
Q2 2021 Aug 16, 2021	BUY	$78.27 - $151.29 $5.09 Million - $9.83 Million	65,000 Added 16.25%	465,000 $65.8 Million
Q1 2021 May 17, 2021	BUY	$94.25 - $132.81 $37.7 Million - $53.1 Million	400,000 New	400,000 $39.9 Million

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Camber Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Camber Capital Management LP with notifications on news.